ORAL MAGNETIC PARTICLES AS A CONTRAST AGENT FOR MR-IMAGING OF THE ABDOMEN A PHASE-III CLINICAL-TRIAL

被引:0
|
作者
VLAHOS, L
GOULIAMOS, A
KALOVIDOURIS, A
ATHANASOPOULOU, A
KOTOULAS, G
LYGIDAKIS, N
LIAOU, A
MATSAIDONIS, D
PAPAVASILIOU, C
机构
关键词
MR IMAGING; ORAL MAGNETIC PARTICLES; MR OF THE ABDOMEN; SUPERPARAMAGNETIC CONTRAST MEDIA;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Twenty patients were investigated with MR imaging of the abdomen before and after the administration of oral magnetic particles in the form of a per os solution for opacification of the gastrointestinal lumen. The parameters which were evaluated were a) distribution of the contrast medium in the gastrointestinal tract, b) delineation with the contrast medium of the region of interest c) image quality of general contract effect of the contrast medium d) diagnostic accuracy compared with CT and plain MRI of the same region. At a concentration of 0.5 mg/oral magnetic particles produced a constant negative signal from the gastro- intestinal. tract in all spin echo sequences (T-1 weighted, T-2 weighted, proton density). Its diagnostic accuracy was similar to CT but better than plain MR examination of the same region in 70 % of the cases. The diagnostic accuracy was inferior in the lower abdomen because of underdistension of the bowel. Perhaps the solution to the problem would be the combined per os and per rectum administration of the contrast medium.
引用
收藏
页码:82 / 85
页数:4
相关论文
共 50 条
  • [1] PERFLUBRON AS AN ORAL CONTRAST AGENT FOR MR-IMAGING - RESULTS OF A PHASE-III CLINICAL-TRIAL
    MATTREY, RF
    TRAMBERT, MA
    BROWN, JJ
    YOUNG, SW
    BRUNETON, JN
    WESBEY, GE
    BALSARA, ZN
    RADIOLOGY, 1994, 191 (03) : 841 - 848
  • [2] GD-DTPA AS AN INTESTINAL CONTRAST AGENT FOR MR IMAGING OF THE LOWER ABDOMEN - PHASE-III CLINICAL-TRIAL
    VLAHOS, L
    GOULIAMOS, A
    CLAUSS, W
    KALOVIDOURIS, A
    ATHANASOPOULOU, A
    PETROULAKIS, A
    HADJIIOANNOU, A
    PAPAVASILIOU, C
    GASTROINTESTINAL RADIOLOGY, 1992, 17 (04): : 300 - 304
  • [3] POSITIVE BOWEL CONTRAST AGENT FOR MR-IMAGING OF THE ABDOMEN - PHASE-II AND PHASE-III CLINICAL-TRIALS
    PATTEN, RM
    LO, SK
    PHILLIPS, JJ
    BOWMAN, SC
    GLAZER, GM
    WALL, SD
    BOVA, JG
    HARRIS, RD
    WHEAT, RL
    JOHNSON, CD
    KRESSEL, HY
    STILLMAN, AE
    HALVORSEN, RA
    MOSS, AA
    RADIOLOGY, 1993, 189 (01) : 277 - 283
  • [4] PHASE-III TRIAL OF ORAL MAGNETIC PARTICLES IN MRI OF ABDOMEN AND PELVIS
    MACVICAR, D
    JACOBSEN, TF
    GUY, R
    HUSBAND, JE
    CLINICAL RADIOLOGY, 1993, 47 (03) : 183 - 188
  • [5] MR-IMAGING OF HEAD AND NECK LESIONS USING HIGH-DOSE GADODIAMIDE INJECTION - A PHASE-III CLINICAL-TRIAL
    VOGL, TJ
    WESTERN, A
    MACK, MG
    KJAERSGAARD, P
    JUERGENS, M
    BALZER, JO
    FELIX, R
    EUROPEAN RADIOLOGY, 1995, 5 (06) : 609 - 614
  • [6] PIPERACILLIN SODIUM (A PHASE-III CLINICAL-TRIAL)
    MACBETH, WAAG
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (05) : 353 - 359
  • [7] STUDENTS EXPERIENCE IN A PHASE-III CLINICAL-TRIAL
    MARSHALL, LL
    FRYE, RF
    MURPHY, JE
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (05): : 1014 - &
  • [8] PHASE-III STUDY OF MN-DPDP IN MR-IMAGING OF THE LIVER - COMPARISON WITH UNENHANCED MR-IMAGING AND CONTRAST-ENHANCED CT
    PADOVANI, B
    LECESNE, R
    RAFFAELLI, C
    LAURENT, FH
    DROUILLARD, J
    BRUNETON, JN
    RADIOLOGY, 1995, 197 : 415 - 415
  • [9] ORAL MAGNETIC PARTICLES IN MR IMAGING OF THE ABDOMEN AND PELVIS
    RINCK, PA
    SMEVIK, O
    NILSEN, G
    KLEPP, O
    ONSRUD, M
    OKSENDAL, A
    BORSETH, A
    RADIOLOGY, 1991, 178 (03) : 775 - 779
  • [10] Phase III clinical experience with a US oral contrast agent in the upper abdomen
    Bree, RL
    Platt, JF
    Bluth, EI
    RADIOLOGY, 1996, 201 : 752 - 752